The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Stem Cell Treatments-Global Market Insights and Sales Trends 2024
Synopsis
Stem Cell Treatment is a method of transplanting healthy stem cells into a patient to repair or replace damaged cells or tissues, thereby achieving the goal of healing. Stem cell transplantation has a wide range of treatments, and can generally treat neurological diseases, immune system diseases, and other medical and surgical diseases.
The global Stem Cell Treatments market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Stem Cell Treatments in various end use industries. The expanding demands from the Nerve Diseases, Immunological Diseases, Musculoskeletal Disorders and Cardiovascular Diseases, are propelling Stem Cell Treatments market. Adipose Tissue-Derived Mesenchymal Stem Cells, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Bone Marrow-Derived Mesenchymal Stem Cells segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Stem Cell Treatments, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Stem Cell Treatments market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Stem Cell Treatments market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Stem Cell Treatments sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Stem Cell Treatments covered in this report include Osiris Therapeutics, Inc, MEDIPOST Co., Ltd, JCR Pharmaceuticals Co., Ltd, FUJIFILM Cellular Dynamics, Inc., Holostem Terapie Avanzate S.r.l., Athersys Inc., CORESTEM, Inc, Mesoblast Ltd. and Regenexx, etc.
The global Stem Cell Treatments market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Osiris Therapeutics, Inc
MEDIPOST Co., Ltd
JCR Pharmaceuticals Co., Ltd
FUJIFILM Cellular Dynamics, Inc.
Holostem Terapie Avanzate S.r.l.
Athersys Inc.
CORESTEM, Inc
Mesoblast Ltd.
Regenexx
Reliance Life Sciences Private Limited
U.S. Stem Cell, Inc.
Vericel Corporation
Pharmicell Co., Ltd
Global Stem Cell Treatments market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Stem Cell Treatments market, Segment by Type:
Adipose Tissue-Derived Mesenchymal Stem Cells
Bone Marrow-Derived Mesenchymal Stem Cells
Cord Blood/Embryonic Stem Cells
Other Cell Sources
Global Stem Cell Treatments market, by Application
Nerve Diseases
Immunological Diseases
Musculoskeletal Disorders
Cardiovascular Diseases
Gastrointestinal Diseases
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Stem Cell Treatments companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Stem Cell Treatment is a method of transplanting healthy stem cells into a patient to repair or replace damaged cells or tissues, thereby achieving the goal of healing. Stem cell transplantation has a wide range of treatments, and can generally treat neurological diseases, immune system diseases, and other medical and surgical diseases.
The global Stem Cell Treatments market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Stem Cell Treatments in various end use industries. The expanding demands from the Nerve Diseases, Immunological Diseases, Musculoskeletal Disorders and Cardiovascular Diseases, are propelling Stem Cell Treatments market. Adipose Tissue-Derived Mesenchymal Stem Cells, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Bone Marrow-Derived Mesenchymal Stem Cells segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Stem Cell Treatments, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Stem Cell Treatments market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Stem Cell Treatments market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Stem Cell Treatments sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Stem Cell Treatments covered in this report include Osiris Therapeutics, Inc, MEDIPOST Co., Ltd, JCR Pharmaceuticals Co., Ltd, FUJIFILM Cellular Dynamics, Inc., Holostem Terapie Avanzate S.r.l., Athersys Inc., CORESTEM, Inc, Mesoblast Ltd. and Regenexx, etc.
The global Stem Cell Treatments market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Osiris Therapeutics, Inc
MEDIPOST Co., Ltd
JCR Pharmaceuticals Co., Ltd
FUJIFILM Cellular Dynamics, Inc.
Holostem Terapie Avanzate S.r.l.
Athersys Inc.
CORESTEM, Inc
Mesoblast Ltd.
Regenexx
Reliance Life Sciences Private Limited
U.S. Stem Cell, Inc.
Vericel Corporation
Pharmicell Co., Ltd
Global Stem Cell Treatments market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Stem Cell Treatments market, Segment by Type:
Adipose Tissue-Derived Mesenchymal Stem Cells
Bone Marrow-Derived Mesenchymal Stem Cells
Cord Blood/Embryonic Stem Cells
Other Cell Sources
Global Stem Cell Treatments market, by Application
Nerve Diseases
Immunological Diseases
Musculoskeletal Disorders
Cardiovascular Diseases
Gastrointestinal Diseases
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Stem Cell Treatments companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Stem Cell Treatments
1.1 Stem Cell Treatments Market Overview
1.1.1 Stem Cell Treatments Product Scope
1.1.2 Stem Cell Treatments Market Status and Outlook
1.2 Global Stem Cell Treatments Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Stem Cell Treatments Market Size by Region (2018-2029)
1.4 Global Stem Cell Treatments Historic Market Size by Region (2018-2023)
1.5 Global Stem Cell Treatments Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Stem Cell Treatments Market Size (2018-2029)
1.6.1 North America Stem Cell Treatments Market Size (2018-2029)
1.6.2 Europe Stem Cell Treatments Market Size (2018-2029)
1.6.3 Asia-Pacific Stem Cell Treatments Market Size (2018-2029)
1.6.4 Latin America Stem Cell Treatments Market Size (2018-2029)
1.6.5 Middle East & Africa Stem Cell Treatments Market Size (2018-2029)
2 Stem Cell Treatments Market by Type
2.1 Introduction
2.1.1 Adipose Tissue-Derived Mesenchymal Stem Cells
2.1.2 Bone Marrow-Derived Mesenchymal Stem Cells
2.1.3 Cord Blood/Embryonic Stem Cells
2.1.4 Other Cell Sources
2.2 Global Stem Cell Treatments Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Stem Cell Treatments Historic Market Size by Type (2018-2023)
2.2.2 Global Stem Cell Treatments Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Stem Cell Treatments Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Stem Cell Treatments Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Stem Cell Treatments Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Stem Cell Treatments Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Stem Cell Treatments Revenue Breakdown by Type (2018-2029)
3 Stem Cell Treatments Market Overview by Application
3.1 Introduction
3.1.1 Nerve Diseases
3.1.2 Immunological Diseases
3.1.3 Musculoskeletal Disorders
3.1.4 Cardiovascular Diseases
3.1.5 Gastrointestinal Diseases
3.1.6 Other
3.2 Global Stem Cell Treatments Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Stem Cell Treatments Historic Market Size by Application (2018-2023)
3.2.2 Global Stem Cell Treatments Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Stem Cell Treatments Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Stem Cell Treatments Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Stem Cell Treatments Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Stem Cell Treatments Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Stem Cell Treatments Revenue Breakdown by Application (2018-2029)
4 Stem Cell Treatments Competition Analysis by Players
4.1 Global Stem Cell Treatments Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Stem Cell Treatments as of 2022)
4.3 Date of Key Players Enter into Stem Cell Treatments Market
4.4 Global Top Players Stem Cell Treatments Headquarters and Area Served
4.5 Key Players Stem Cell Treatments Product Solution and Service
4.6 Competitive Status
4.6.1 Stem Cell Treatments Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Osiris Therapeutics, Inc
5.1.1 Osiris Therapeutics, Inc Profile
5.1.2 Osiris Therapeutics, Inc Main Business
5.1.3 Osiris Therapeutics, Inc Stem Cell Treatments Products, Services and Solutions
5.1.4 Osiris Therapeutics, Inc Stem Cell Treatments Revenue (US$ Million) & (2018-2023)
5.1.5 Osiris Therapeutics, Inc Recent Developments
5.2 MEDIPOST Co., Ltd
5.2.1 MEDIPOST Co., Ltd Profile
5.2.2 MEDIPOST Co., Ltd Main Business
5.2.3 MEDIPOST Co., Ltd Stem Cell Treatments Products, Services and Solutions
5.2.4 MEDIPOST Co., Ltd Stem Cell Treatments Revenue (US$ Million) & (2018-2023)
5.2.5 MEDIPOST Co., Ltd Recent Developments
5.3 JCR Pharmaceuticals Co., Ltd
5.3.1 JCR Pharmaceuticals Co., Ltd Profile
5.3.2 JCR Pharmaceuticals Co., Ltd Main Business
5.3.3 JCR Pharmaceuticals Co., Ltd Stem Cell Treatments Products, Services and Solutions
5.3.4 JCR Pharmaceuticals Co., Ltd Stem Cell Treatments Revenue (US$ Million) & (2018-2023)
5.3.5 FUJIFILM Cellular Dynamics, Inc. Recent Developments
5.4 FUJIFILM Cellular Dynamics, Inc.
5.4.1 FUJIFILM Cellular Dynamics, Inc. Profile
5.4.2 FUJIFILM Cellular Dynamics, Inc. Main Business
5.4.3 FUJIFILM Cellular Dynamics, Inc. Stem Cell Treatments Products, Services and Solutions
5.4.4 FUJIFILM Cellular Dynamics, Inc. Stem Cell Treatments Revenue (US$ Million) & (2018-2023)
5.4.5 FUJIFILM Cellular Dynamics, Inc. Recent Developments
5.5 Holostem Terapie Avanzate S.r.l.
5.5.1 Holostem Terapie Avanzate S.r.l. Profile
5.5.2 Holostem Terapie Avanzate S.r.l. Main Business
5.5.3 Holostem Terapie Avanzate S.r.l. Stem Cell Treatments Products, Services and Solutions
5.5.4 Holostem Terapie Avanzate S.r.l. Stem Cell Treatments Revenue (US$ Million) & (2018-2023)
5.5.5 Holostem Terapie Avanzate S.r.l. Recent Developments
5.6 Athersys Inc.
5.6.1 Athersys Inc. Profile
5.6.2 Athersys Inc. Main Business
5.6.3 Athersys Inc. Stem Cell Treatments Products, Services and Solutions
5.6.4 Athersys Inc. Stem Cell Treatments Revenue (US$ Million) & (2018-2023)
5.6.5 Athersys Inc. Recent Developments
5.7 CORESTEM, Inc
5.7.1 CORESTEM, Inc Profile
5.7.2 CORESTEM, Inc Main Business
5.7.3 CORESTEM, Inc Stem Cell Treatments Products, Services and Solutions
5.7.4 CORESTEM, Inc Stem Cell Treatments Revenue (US$ Million) & (2018-2023)
5.7.5 CORESTEM, Inc Recent Developments
5.8 Mesoblast Ltd.
5.8.1 Mesoblast Ltd. Profile
5.8.2 Mesoblast Ltd. Main Business
5.8.3 Mesoblast Ltd. Stem Cell Treatments Products, Services and Solutions
5.8.4 Mesoblast Ltd. Stem Cell Treatments Revenue (US$ Million) & (2018-2023)
5.8.5 Mesoblast Ltd. Recent Developments
5.9 Regenexx
5.9.1 Regenexx Profile
5.9.2 Regenexx Main Business
5.9.3 Regenexx Stem Cell Treatments Products, Services and Solutions
5.9.4 Regenexx Stem Cell Treatments Revenue (US$ Million) & (2018-2023)
5.9.5 Regenexx Recent Developments
5.10 Reliance Life Sciences Private Limited
5.10.1 Reliance Life Sciences Private Limited Profile
5.10.2 Reliance Life Sciences Private Limited Main Business
5.10.3 Reliance Life Sciences Private Limited Stem Cell Treatments Products, Services and Solutions
5.10.4 Reliance Life Sciences Private Limited Stem Cell Treatments Revenue (US$ Million) & (2018-2023)
5.10.5 Reliance Life Sciences Private Limited Recent Developments
5.11 U.S. Stem Cell, Inc.
5.11.1 U.S. Stem Cell, Inc. Profile
5.11.2 U.S. Stem Cell, Inc. Main Business
5.11.3 U.S. Stem Cell, Inc. Stem Cell Treatments Products, Services and Solutions
5.11.4 U.S. Stem Cell, Inc. Stem Cell Treatments Revenue (US$ Million) & (2018-2023)
5.11.5 U.S. Stem Cell, Inc. Recent Developments
5.12 Vericel Corporation
5.12.1 Vericel Corporation Profile
5.12.2 Vericel Corporation Main Business
5.12.3 Vericel Corporation Stem Cell Treatments Products, Services and Solutions
5.12.4 Vericel Corporation Stem Cell Treatments Revenue (US$ Million) & (2018-2023)
5.12.5 Vericel Corporation Recent Developments
5.13 Pharmicell Co., Ltd
5.13.1 Pharmicell Co., Ltd Profile
5.13.2 Pharmicell Co., Ltd Main Business
5.13.3 Pharmicell Co., Ltd Stem Cell Treatments Products, Services and Solutions
5.13.4 Pharmicell Co., Ltd Stem Cell Treatments Revenue (US$ Million) & (2018-2023)
5.13.5 Pharmicell Co., Ltd Recent Developments
6 North America
6.1 North America Stem Cell Treatments Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Stem Cell Treatments Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Stem Cell Treatments Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Stem Cell Treatments Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Stem Cell Treatments Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Stem Cell Treatments Market Dynamics
11.1 Stem Cell Treatments Industry Trends
11.2 Stem Cell Treatments Market Drivers
11.3 Stem Cell Treatments Market Challenges
11.4 Stem Cell Treatments Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
